Mohammad K. Eldomery

ORCID: 0009-0005-5699-6008
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Genomics and Rare Diseases
  • Genomic variations and chromosomal abnormalities
  • Genetics and Neurodevelopmental Disorders
  • Genetic factors in colorectal cancer
  • Congenital heart defects research
  • RNA modifications and cancer
  • Clinical practice guidelines implementation
  • Acute Myeloid Leukemia Research
  • RNA and protein synthesis mechanisms
  • Healthcare cost, quality, practices
  • Cancer Genomics and Diagnostics
  • Mitochondrial Function and Pathology
  • Medical Coding and Health Information
  • Glioma Diagnosis and Treatment
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • RNA Research and Splicing
  • Chromatin Remodeling and Cancer
  • Hematological disorders and diagnostics
  • Cardiomyopathy and Myosin Studies
  • Neuroblastoma Research and Treatments
  • Genetic and Kidney Cyst Diseases
  • Machine Learning in Bioinformatics
  • Renal cell carcinoma treatment
  • Renal and related cancers
  • BRCA gene mutations in cancer

St. Jude Children's Research Hospital
2024-2025

Baylor College of Medicine
2015-2022

Washington Center
2022

Texas Children's Hospital
2022

Riyadh Armed Forces Hospital
2020

Indiana University – Purdue University Indianapolis
2017-2020

Indiana University School of Medicine
2017-2020

University of Iowa
2020

Yale University
2020

University of Nebraska Medical Center
2020

Asbjørg Stray‐Pedersen Hanne Sørmo Sorte Pubudu Samarakoon Tomasz Gambin Iván K. Chinn and 88 more Zeynep H. Coban Akdemir Hans Christian Erichsen Lisa R. Forbes Shen Gu Bo Yuan Shalini N. Jhangiani Donna M. Muzny Olaug K. Rødningen Ying Sheng Sarah K. Nicholas Lenora M. Noroski Filiz O. Seeborg Carla M. Davis Debra Canter Emily M. Mace Timothy J. Vece Carl E. Allen Harshal Abhyankar Philip M. Boone Christine R. Beck Wojciech Wiszniewski Børre Fevang Pål Aukrust Geir E. Tjønnfjord Tobias Gedde‐Dahl Henrik Hjorth‐Hansen Ingunn Dybedal Ingvild Nordøy Silje F. Jørgensen Tore G. Abrahamsen Torstein Øverland Anne Grete Bechensteen Vegard Skogen Liv Osnes Mari Ann Kulseth Trine Prescott Cecilie F. Rustad Ketil Heimdal John W. Belmont Nicholas L. Rider Javier Chinen Tram N. Cao Eric A. Smith María Soledad Caldirola Liliana Bezrodnik Saúl Oswaldo Lugo Reyes Francisco Espinosa‐Rosales Nina Denisse Guerrero-Cursaru Luis Alberto Pedroza M. Cecilia Poli José Luis Franco Claudia Milena Trujillo Vargas Juan Carlos Aldave Becerra Nicola Wright Thomas B. Issekutz Andrew C. Issekutz Jordan K. Abbott Jason W. Caldwell Diana K. Bayer Alice Chan Alessandro Aiuti Caterina Cancrini Eva Holmberg Christina West Magnus Burstedt Ender Karaca Gözde Yeşil Hasibe Artaç Yavuz Bayram Mehmed M. Atik Mohammad K. Eldomery Mohammad Ehlayel Stephen Jolles Berit Flatø Alison A. Bertuch I. Celine Hanson Victor Wei Zhang Lee-Jun Wong Jianhong Hu Magdalena Walkiewicz Yaping Yang Christine M. Eng Eric Boerwinkle Richard A. Gibbs William T. Shearer Robert Lyle Jordan S. Orange James R. Lupski

10.1016/j.jaci.2016.05.042 article EN Journal of Allergy and Clinical Immunology 2016-07-17

Given the rarity of most single-gene Mendelian disorders, concerted efforts data exchange between clinical and scientific communities are critical to optimize molecular diagnosis novel disease gene discovery. We designed implemented protocols for study cases which a plausible was not achieved in genomics diagnostic laboratory (i.e. unsolved exomes). Such were recruited research further analyses, order potentially: (1) accelerate discovery; (2) increase yield whole exome sequencing (WES); (3)...

10.1186/s13073-017-0412-6 article EN cc-by Genome Medicine 2017-03-21

We developed an algorithm, HMZDelFinder, that uses whole exome sequencing (WES) data to identify rare and intragenic homozygous hemizygous (HMZ) deletions may represent complete loss-of-function of the indicated gene. HMZDelFinder was applied 4866 samples in Baylor-Hopkins Center for Mendelian Genomics (BHCMG) cohort detected 773 HMZ deletion calls (567 or 206 hemizygous) with estimated sensitivity 86.5% (82% single-exonic 88% multi-exonic calls) precision 78% (53% 96% calls). Out...

10.1093/nar/gkw1237 article EN cc-by-nc Nucleic Acids Research 2016-11-29

Dominant mutations in CACNA1A, encoding the α-1A subunit of neuronal P/Q type voltage-dependent Ca2+ channel, can cause diverse neurological phenotypes. Rare cases markedly severe early onset developmental delay and congenital ataxia be due to de novo CACNA1A missense alleles, with variants affecting S4 transmembrane segments some which are reported loss-of-function. Exome sequencing five individuals identified one novel variant (p.R1673P), a girl global progressive cerebellar atrophy,...

10.1371/journal.pgen.1006905 article EN cc-by PLoS Genetics 2017-07-24

Abstract De novo variants in DDX 3X account for 1–3% of unexplained intellectual disability ( ID ) cases and are amongst the most common causes especially females. Forty‐seven patients (44 females, 3 males) have been described. We identified 31 additional individuals carrying 29 unique variants, including 30 postnatal with complex clinical presentations developmental delay or , one fetus abnormal ultrasound findings. Rare novel phenotypes observed include respiratory problems, congenital...

10.1002/acn3.622 article EN cc-by-nc-nd Annals of Clinical and Translational Neurology 2018-09-15

Mitochondrial presequence proteases perform fundamental functions as they process about 70 % of all mitochondrial preproteins that are encoded in the nucleus and imported posttranslationally. The intermediate protease MIP/Oct1, which carries out precursor processing, has not yet been established to have a role human disease. Whole exome sequencing was performed on four unrelated probands with left ventricular non-compaction (LVNC), developmental delay (DD), seizures, severe hypotonia....

10.1186/s13073-016-0360-6 article EN cc-by Genome Medicine 2016-10-18

<title>Abstract</title> Pediatric acute myeloid leukemia (AML) exhibits distinct genetic characteristics, including unique driver alterations and mutations with prognostic therapeutic significance. Emerging rare, recurrent abnormalities their associations outcomes emphasize the need for high-throughput molecular diagnostic tools. Whole genome sequencing (WGS) reliably detects key AML biomarkers such as structural variants, mutations, copy number alterations. transcriptome (WTS) complements...

10.21203/rs.3.rs-5775959/v1 preprint EN cc-by Research Square (Research Square) 2025-01-22

Abstract Background FOXR2 activation is regarded as pathognomonic for CNS neuroblastoma (NB). However, a comprehensive understanding of the landscape tumors exhibiting lacking. Methods Histopathologic, molecular, imaging, and clinical data 42 with overexpression identified through screening institutional datasets published cases were analyzed. Results Among tumors, 21 (50.0%) high-grade gliomas (HGGs), 18 (42.9%) embryonal tumors. The HGGs included ten H3 K27M-mutant diffuse midline (DMGs)...

10.1093/neuonc/noaf076 article EN Neuro-Oncology 2025-04-15

The association of childhood cancer with Lynch syndrome is not established compared the significant pediatric risk in recessive constitutional mismatch repair deficiency (CMMRD).We describe clinical features, germline analysis, and tumor genomic profiling patients among enrolled studies.There were six 773 (0.8%) solid tumors identified syndrome, defined as a heterozygous pathogenic variant one (MMR) genes (three MSH6, two MLH1, MSH2). Tumor analysis demonstrated evidence for somatic second...

10.1002/pbc.29859 article EN Pediatric Blood & Cancer 2022-06-17
Coming Soon ...